Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 29, 2024 (Week 26)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 14,032 35,117 664,759 822,526
New England 601 886 18,885 21,388
Connecticut - 0 - 1,155
Maine 43 80 1,347 1,456
Massachusetts 405 647 13,658 14,164
New Hampshire 59 79 1,136 1,407
Rhode Island 79 389 2,091 2,503
Vermont 15 35 653 703
Middle Atlantic 2,012 4,380 90,709 99,368
New Jersey 499 788 15,859 17,904
New York (excluding New York City) 747 957 19,422 20,793
New York City - 1,565 29,424 33,196
Pennsylvania 766 1,168 26,004 27,475
East North Central 1,751 4,539 81,024 111,917
Illinois 72 1,289 15,801 32,740
Indiana 417 726 15,117 17,495
Michigan 182 1,019 14,123 21,050
Ohio 681 1,220 24,461 28,011
Wisconsin 399 533 11,522 12,621
West North Central 925 2,132 43,742 49,282
Iowa 133 313 5,877 6,950
Kansas 142 304 5,948 6,770
Minnesota 126 485 9,737 11,075
Missouri 483 746 14,859 15,748
Nebraska - 249 3,912 4,528
North Dakota 41 87 1,498 1,739
South Dakota - 118 1,911 2,472
South Atlantic 3,011 12,278 166,698 191,235
Delaware - 227 2,565 2,906
District of Columbia - 200 3,119 4,258
Florida 1,723 6,940 54,916 56,439
Georgia - 1,534 29,919 37,331
Maryland - 1,009 13,420 17,063
North Carolina 5 1,433 25,303 33,548
South Carolina 551 820 16,285 16,611
Virginia 704 934 19,132 20,886
West Virginia 28 115 2,039 2,193
East South Central 866 1,974 29,506 53,536
Alabama 580 895 16,038 17,139
Kentucky 179 575 7,553 7,919
Mississippi 107 1,004 5,915 10,288
Tennessee - 317 - 18,190
West South Central 814 4,740 83,135 113,351
Arkansas 169 394 7,833 9,314
Louisiana 446 891 16,115 18,312
Oklahoma 43 383 4,923 9,437
Texas 156 3,280 54,264 76,288
Mountain 1,251 2,667 49,647 58,490
Arizona 436 929 18,790 20,362
Colorado 288 856 11,658 12,836
Idaho 88 145 2,576 2,934
Montana 47 98 1,628 1,810
Nevada 187 374 5,612 8,406
New Mexico 19 253 3,632 5,692
Utah 163 255 5,028 5,514
Wyoming 23 52 723 936
Pacific 2,801 5,069 101,413 123,959
Alaska 69 125 2,453 2,617
California 2,099 3,909 83,229 96,327
Hawaii - 150 - 3,171
Oregon 283 382 7,000 7,542
Washington 350 609 8,731 14,302
U.S. Territories - 119 638 2,408
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 119 638 2,408
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 3 12 28
Total 14,033 35,160 665,409 824,962
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.